but not more than 15 consecutive business days prior to the date on which the Board of Directors of the Company has resolved to propose the shareholders’ meeting approves the Company to offer newly
2016 that had loss about 10.58 million baht to have profit in 2017 estimated at 0.69 million baht. The company received the profit in proportion of investment 60% of 0.41 million baht. 3. Legacy Asia
rights of the outstanding voting shares; (c) the holding company of the company in (b) and its consecutive holding companies whose shareholding in each company is more than fifty percent of the total
proportion to their shareholdings (Right Offering); 4.2 to allocate the remaining shares from the offering to existing shareholders (Right Offering) and the allocation of the shares pursuant to which the
selling medical equipment 60.65 73.92 Administrative expenses 109.64 105.99 Finance costs 22.86 24.24 Finance costs (net) 20.87 21.71 Proportion of cost of medical treatment / revenue of medical treatment
590.59 553.11 Cost of selling medical equipment 65.30 57.70 Administrative expenses 112.97 109.49 Finance costs 19.32 24.93 Finance costs (net) 16.90 22.87 Proportion of cost of medical treatment / revenue
Company shall subscribe the newly issued share in proportion of 108,022 shares and the newly issued share in portion of the unsubscribed shares of other shareholders of 40,604 shares. As subscription of
has applied the calculation from the volume weighted average price of the Company’s ordinary shares traded on the Stock Exchange of Thailand (“SET”) 7 consecutive working days prior to the date on which
Accounting Committee on Accounting Education and Technology, the Federation of Accounting Professions of Thailand under the Royal Patronage of His Majesty the King, for two consecutive terms • Audit
the top 100 for outstanding ESG performance in terms of environmental, social and governance (ESG 100) by Thaipat Institute for the fourth consecutive year and also the company’s securities has selected